
Medical board survey shows increased prosecution of overprescribers and need for addiction education

Medical board survey shows increased prosecution of overprescribers and need for addiction education

Public support exists for access to experimental drugs

FDA approves Verigene test for warfarin (Coumadin) metabolism

Drug mix-ups occur frequently in Pennsylvania

Lamisil oral granules are approved by the FDA for tinea capitis

Docetaxel approved for squamous cell head and neck cancer

Another influenza vaccine approved for seasonal flu

FDA advisory committee to discuss OTC cough/ cold products in children under six

Rite Aid celebrates American Pharmacists Month with contest

Take Care Health Systems to expand with Walgreens

NACDS thanks Senate for pharmacy provision for military families.

Bartell, Novartis launch FluGram prepaid influenza vaccination card.

The Fair Medicaid Drug Payment Act of 2007 would fix the average manufacturers price rule and promote generic drugs.

A bipartisan group of lawmakers has formed the Congressional Community Pharmacy Coalition to advocate on pharmacy issues.

FDA proposes chlorofluorocarbon (CFC) removal from epinephrine inhalers.

Wyeth's new Advil Maximum Strength waiting for FDA approval.

Emergency contraception policy sparks debate.

California pharmacy board is stepping up its enforcement of its pharmacy consultation with stiffer fines.

In the face of increasing pharmacy costs at Delaware, Maryland, and Virginia pharmacies, health plans push beneficiaries to mail-order facilities

Rite Aid integration of Brooks Eckerd stores progressing

Baxa replaces malfunctioning IV mixing software

FDA approves 300-mg strength of clopidogrel

CMS announces details of the 2008 prescription drug plans

FDA orders unapproved hydrocodone makers to cease marketing

Teamsters at AmerisourceBergen to rally for fair contract settlement.

Albemarle to increase price of ibuprofen

NACDS applauds passage of House bill to delay tamper-resistant paper requirement

QIO sets up new MTM program for Maryland and District of Columbia

PhRMA testifies to Congress about the threat of drug counterfeiting